Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Eidos Therapeutics, Inc. | 24,575,501 | reported | 03 Jul 2019 | tx 16+25,119,525−16,285,176 |
| BridgeBio Pharma, Inc. | 267,174 | reported | 21 May 2026 | tx 349+19,658,582−20,799,342 |
| Maze Therapeutics, Inc. | 33,417 | reported | 27 Mar 2026 | tx 1+33,417 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2026 | SALE | BridgeBio Pharma, Inc. | 2,256 | 67.57 USD | 10b5-1 |
| 21 May 2026 | SALE | BridgeBio Pharma, Inc. | 6,725 | 68.30 USD | 10b5-1 |
| 21 May 2026 | SALE | BridgeBio Pharma, Inc. | 5,072 | 69.22 USD | 10b5-1 |
| 21 May 2026 | SALE | BridgeBio Pharma, Inc. | 11,250 | 70.48 USD | 10b5-1 |
| 21 May 2026 | SALE | BridgeBio Pharma, Inc. | 800 | 70.92 USD | 10b5-1 |
| 16 May 2026 | EXERCISE | BridgeBio Pharma, Inc. | 33,544 | — | |
| 16 May 2026 | EXERCISE | BridgeBio Pharma, Inc. | 19,599 | — | |
| 16 May 2026 | EXERCISE | BridgeBio Pharma, Inc. | 11,553 | — | |
| 16 May 2026 | EXERCISE | BridgeBio Pharma, Inc. | 6,519 | — | |
| 16 May 2026 | TAX_WITHHOLDING | BridgeBio Pharma, Inc. | 36,236 | 66.13 USD | |
| 16 May 2026 | EXERCISE | BridgeBio Pharma, Inc. | 33,544 | 0.00 USD | deriv |
| 16 May 2026 | EXERCISE | BridgeBio Pharma, Inc. | 19,599 | 0.00 USD | deriv |
| 16 May 2026 | EXERCISE | BridgeBio Pharma, Inc. | 11,553 | 0.00 USD | deriv |
| 16 May 2026 | EXERCISE | BridgeBio Pharma, Inc. | 6,519 | 0.00 USD | deriv |
| 07 May 2026 | SALE | BridgeBio Pharma, Inc. | 11,217 | 67.50 USD | 10b5-1 |
| 07 May 2026 | SALE | BridgeBio Pharma, Inc. | 8,333 | 68.38 USD | 10b5-1 |
| 07 May 2026 | SALE | BridgeBio Pharma, Inc. | 450 | 69.09 USD | 10b5-1 |
| 07 May 2026 | SALE | BridgeBio Pharma, Inc. | 11,217 | 67.49 USD | 10b5-1 |
| 07 May 2026 | SALE | BridgeBio Pharma, Inc. | 8,334 | 68.38 USD | 10b5-1 |
| 07 May 2026 | SALE | BridgeBio Pharma, Inc. | 449 | 69.09 USD | 10b5-1 |
| 08 May 2026 | SALE | BridgeBio Pharma, Inc. | 13,973 | 66.65 USD | 10b5-1 |
| 08 May 2026 | SALE | BridgeBio Pharma, Inc. | 5,077 | 67.35 USD | 10b5-1 |
| 08 May 2026 | SALE | BridgeBio Pharma, Inc. | 950 | 68.35 USD | 10b5-1 |
| 08 May 2026 | SALE | BridgeBio Pharma, Inc. | 13,974 | 66.65 USD | 10b5-1 |
| 08 May 2026 | SALE | BridgeBio Pharma, Inc. | 5,076 | 67.35 USD | 10b5-1 |